January 28 (SeeNews) - Slovenian pharmaceutical company Lek, a subsidiary of Novartis, is contemplating the construction of a 82.6 million euro ($92.2 million) factory in Ljubljana, local media reported.
The costruction of the factory, which will be equipped with novel insulator technology for aseptic processes, depends on the approval of 6.6 million euro state aid by the government, public broadcaster RTV reported on Thursday.
The government is expected to decide next week whether to approve the aid, RTV reported.
Lek, which is expected to start filling and packing Pfizer coronavirus vaccines by the summer of 2022, aims to open 121 jobs at the new factory, RTV added.
Since taking over Lek in 2002, Novartis has invested about 3 billion euro in Slovenia, including 420 million euro in the last two years.
($ = 0.8963 euro)